Mar 26, 2019
Immutep to Host Eftilagimod Alpha Clinical Development Update Global Webcast
Mar 20, 2019
Immutep Announces United States Patent Grant for Eftilagimod Alpha in Cancer
Mar 17, 2019
Immutep to Present IMP761 Preclinical Results in Global Webcast
Mar 06, 2019
Immutep Presents Positive IMP761 Preclinical Results at 14th Congress of European Crohn’s and Colitis Organisation
Immutep doses First Patient in TACTI-002 Phase II Trial
